Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 11:52:40 UTC
Update Date2021-09-26 23:06:39 UTC
HMDB IDHMDB0253439
Secondary Accession NumbersNone
Metabolite Identification
Common NameBenzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-
DescriptionBenzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- belongs to the class of organic compounds known as quinoxalines. Quinoxalines are compounds containing a quinoxaline moiety, a bicyclic heterocycle made up of a benzene ring fused to a pyrazine ring. Based on a literature review very few articles have been published on Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-. This compound has been identified in human blood as reported by (PMID: 31557052 ). Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1h-imidazol-2-yl)methyl)- is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
3-((5-(6-Methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzamideMeSH
Chemical FormulaC25H20N6O
Average Molecular Weight420.476
Monoisotopic Molecular Weight420.169859288
IUPAC Name3-{[5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl]methyl}benzamide
Traditional Name3-{[4-(6-methylpyridin-2-yl)-5-(quinoxalin-6-yl)-3H-imidazol-2-yl]methyl}benzamide
CAS Registry NumberNot Available
SMILES
CC1=CC=CC(=N1)C1=C(N=C(CC2=CC=CC(=C2)C(N)=O)N1)C1=CC2=NC=CN=C2C=C1
InChI Identifier
InChI=1S/C25H20N6O/c1-15-4-2-7-20(29-15)24-23(17-8-9-19-21(14-17)28-11-10-27-19)30-22(31-24)13-16-5-3-6-18(12-16)25(26)32/h2-12,14H,13H2,1H3,(H2,26,32)(H,30,31)
InChI KeyRYKSGWSKILPDDY-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as quinoxalines. Quinoxalines are compounds containing a quinoxaline moiety, a bicyclic heterocycle made up of a benzene ring fused to a pyrazine ring.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassDiazanaphthalenes
Sub ClassBenzodiazines
Direct ParentQuinoxalines
Alternative Parents
Substituents
  • Quinoxaline
  • Benzamide
  • Benzoic acid or derivatives
  • 2,4,5-trisubstituted-imidazole
  • Trisubstituted imidazole
  • Benzoyl
  • Methylpyridine
  • Monocyclic benzene moiety
  • Benzenoid
  • Pyridine
  • Pyrazine
  • Azole
  • Heteroaromatic compound
  • Imidazole
  • Primary carboxylic acid amide
  • Carboxamide group
  • Carboxylic acid derivative
  • Azacycle
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Organic oxygen compound
  • Organooxygen compound
  • Organonitrogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.16ALOGPS
logP2.89ChemAxon
logS-4.8ALOGPS
pKa (Strongest Acidic)11.75ChemAxon
pKa (Strongest Basic)5.15ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area110.44 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity120.49 m³·mol⁻¹ChemAxon
Polarizability45.41 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+195.35630932474
DeepCCS[M-H]-192.96130932474
DeepCCS[M-2H]-225.84430932474
DeepCCS[M+Na]+201.4630932474

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-CC1=CC=CC(=N1)C1=C(N=C(CC2=CC=CC(=C2)C(N)=O)N1)C1=CC2=NC=CN=C2C=C15258.6Standard polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-CC1=CC=CC(=N1)C1=C(N=C(CC2=CC=CC(=C2)C(N)=O)N1)C1=CC2=NC=CN=C2C=C14201.4Standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-CC1=CC=CC(=N1)C1=C(N=C(CC2=CC=CC(=C2)C(N)=O)N1)C1=CC2=NC=CN=C2C=C14572.8Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C)=C3)[NH]2)=N14266.3Semi standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C)=C3)[NH]2)=N14118.1Standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C)=C3)[NH]2)=N15587.2Standard polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TMS,isomer #2CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(N)=O)=C3)N2[Si](C)(C)C)=N14271.5Semi standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TMS,isomer #2CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(N)=O)=C3)N2[Si](C)(C)C)=N13820.3Standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TMS,isomer #2CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(N)=O)=C3)N2[Si](C)(C)C)=N15830.9Standard polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C)=C3)N2[Si](C)(C)C)=N14219.3Semi standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C)=C3)N2[Si](C)(C)C)=N13932.6Standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C)=C3)N2[Si](C)(C)C)=N15212.5Standard polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TMS,isomer #2CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C3)[NH]2)=N14094.0Semi standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TMS,isomer #2CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C3)[NH]2)=N14039.1Standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TMS,isomer #2CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C3)[NH]2)=N15264.6Standard polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,3TMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C3)N2[Si](C)(C)C)=N14113.1Semi standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,3TMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C3)N2[Si](C)(C)C)=N13836.7Standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,3TMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C3)N2[Si](C)(C)C)=N14956.1Standard polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TBDMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C3)[NH]2)=N14419.8Semi standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TBDMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C3)[NH]2)=N14274.3Standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TBDMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C3)[NH]2)=N15561.1Standard polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TBDMS,isomer #2CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(N)=O)=C3)N2[Si](C)(C)C(C)(C)C)=N14468.9Semi standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TBDMS,isomer #2CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(N)=O)=C3)N2[Si](C)(C)C(C)(C)C)=N14020.8Standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TBDMS,isomer #2CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(N)=O)=C3)N2[Si](C)(C)C(C)(C)C)=N15737.5Standard polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TBDMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C3)N2[Si](C)(C)C(C)(C)C)=N14564.3Semi standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TBDMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C3)N2[Si](C)(C)C(C)(C)C)=N14277.1Standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TBDMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C3)N2[Si](C)(C)C(C)(C)C)=N15218.8Standard polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TBDMS,isomer #2CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3)[NH]2)=N14476.3Semi standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TBDMS,isomer #2CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3)[NH]2)=N14322.6Standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TBDMS,isomer #2CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3)[NH]2)=N15211.6Standard polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,3TBDMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3)N2[Si](C)(C)C(C)(C)C)=N14633.5Semi standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,3TBDMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3)N2[Si](C)(C)C(C)(C)C)=N14288.1Standard non polar33892256
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,3TBDMS,isomer #1CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3)N2[Si](C)(C)C(C)(C)C)=N15018.3Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- GC-MS (Non-derivatized) - 70eV, Positivesplash10-0zgl-1319700000-8326f46eb20c41d7a1c12021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- 10V, Positive-QTOFsplash10-0fk9-0000900000-4befade8474cf1a247992021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- 20V, Positive-QTOFsplash10-0uk9-0001900000-47906c66ae492e9365712021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- 40V, Positive-QTOFsplash10-0fb9-0019200000-3c357d865af69c9cd7ab2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- 10V, Negative-QTOFsplash10-014i-0000900000-ac34731c141788ff95f22021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- 20V, Negative-QTOFsplash10-014i-0001900000-93d06866bc8b67d49a7b2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- 40V, Negative-QTOFsplash10-0ufu-4849100000-ae10ab29d6a43c7d6aa22021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID9850848
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound11676119
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]